# PDZD2

## Overview
PDZD2 is a gene that encodes the protein PDZ domain containing 2, which is characterized by the presence of multiple PDZ domains. These domains are integral to the protein's role in facilitating protein-protein interactions, particularly in clustering plasma-membrane-associated proteins and participating in intracellular signaling pathways (Yeung2003Proteolytic). The protein is primarily localized to the endoplasmic reticulum and the nucleus, indicating its involvement in diverse cellular functions. PDZD2 undergoes caspase-dependent proteolytic cleavage to produce a secreted form, sPDZD2, which retains two PDZ domains and is involved in forming extracellular protein complexes (Yeung2003Proteolytic). Functionally, PDZD2 is implicated in the regulation of insulin secretion in pancreatic β-cells and has been associated with the modulation of various signaling pathways, including those related to cancer and metabolic disorders (Tsang2010Increased; Tam2008The). The protein's interactions and regulatory roles suggest its potential significance in therapeutic strategies for conditions such as diabetes and cancer.

## Structure
PDZD2 is a multi-PDZ-domain protein, characterized by the presence of multiple PDZ domains, which are known for facilitating protein-protein interactions and are involved in clustering plasma-membrane-associated proteins and intracellular signaling (Yeung2003Proteolytic). The protein undergoes caspase-dependent proteolytic cleavage, resulting in a secreted form known as sPDZD2, which contains two PDZ domains (Yeung2003Proteolytic). These domains are crucial for the protein's function, allowing it to interact with various proteins and potentially form extracellular protein complexes (Yeung2003Proteolytic).

The PDZ domains in PDZD2 share structural similarities with those in pro-interleukin-16 (pro-IL-16), particularly the conservation of a tryptophan residue in the ligand-binding pocket, which is important for binding properties (Yeung2003Proteolytic). PDZD2 is primarily localized to the endoplasmic reticulum but also shows nuclear expression, suggesting potential nuclear functions (Yeung2003Proteolytic). The protein is expressed in several tissues, including the pancreas, where it is involved in the growth and differentiation of pancreatic progenitor cells (Suen2008PDZdomain). PDZD2 may exist in multiple isoforms due to alternative splicing, although specific details on these isoforms are not provided in the context.

## Function
PDZD2, also known as PDZ domain containing 2, is a multi-PDZ-domain protein that plays a significant role in cellular signaling and structural organization. It is primarily localized to the endoplasmic reticulum (ER) and the nucleus, where it is involved in protein-protein interactions, clustering of plasma-membrane-associated proteins, and intracellular signaling (Yeung2003Proteolytic). PDZD2 undergoes proteolytic cleavage to produce a secreted peptide, sPDZD2, which contains two PDZ domains. This cleavage is caspase-dependent, similar to the processing of prointerleukin-16 (pro-IL-16) (Yeung2003Proteolytic).

In pancreatic β-cells, PDZD2 is enriched and plays a role in regulating insulin secretion, which is crucial for maintaining glucose homeostasis. PDZD2-deficient mice exhibit enhanced glucose tolerance and increased basal insulin secretion, indicating its involvement in insulin exocytosis (Tsang2010Increased). In human fetal pancreatic progenitor cells (PPCs), PDZD2 promotes cell proliferation and influences differentiation processes. Its secreted form, sPDZD2, enhances the expression of L-type Ca v 1.2 channels, facilitating calcium ion influx necessary for insulin secretion (Leung2009PDZDomain). PDZD2's role in these processes suggests its potential importance in the development of therapies for diabetes (Leung2009PDZDomain).

## Clinical Significance
PDZD2 has been implicated in various diseases, particularly in cancer and metabolic disorders, through alterations in its expression or interactions. In cancer, secreted PDZD2 (sPDZD2) has been shown to induce senescence or quiescence in prostate, breast, and liver cancer cells by activating the p53 tumor suppressor pathway. This activation can lead to cell cycle arrest or apoptosis, suggesting a potential role for sPDZD2 as a tumor suppressor. The antiproliferative effects of sPDZD2 are mediated through p53-dependent pathways, although the involvement of p21 CIP1/WAF1 varies among different cancer types (Tam2008The). 

In the context of metabolic disorders, sPDZD2 is involved in regulating insulin secretion and pancreatic β-cell function. Alterations in PDZD2 expression can lead to defects in insulin secretion, as observed in studies using INS-1E cells and mouse islets. The insulinotropic effects of sPDZD2 are mediated through a PKA-dependent mechanism, similar to the action of GLP-1, a known insulinotropic peptide hormone (Fai2020Secreted). These findings suggest that PDZD2 may play a role in glucose homeostasis and could be relevant in the pathogenesis of diabetes.

## Interactions
PDZD2, a multi-PDZ domain protein, is involved in various protein-protein interactions that influence cellular processes. It directly binds to the intracellular loops of the sensory neuron-specific sodium channels NaV1.8 and NaV1.7, which are crucial for nociception. This interaction is essential for the functional expression of NaV1.8 in sensory neurons, although PDZD2 does not facilitate its translocation to the plasma membrane (Shao2009A).

PDZD2 also interacts with other proteins through its PDZ domains, including δ-catenin/NPRAP, p0071, and the GABA B R2 receptor, affecting their stability and signaling pathways (Shao2009A). The protein undergoes caspase-dependent proteolytic cleavage to generate a secreted form, sPDZD2, which contains two PDZ domains. This secreted form can interact with multiple proteins, facilitating the formation of extracellular protein complexes (Yeung2003Proteolytic).

In cancer cells, sPDZD2 interacts with the p53 pathway, inducing senescence or quiescence through transcriptional activation of p53. This interaction is crucial for its antiproliferative effects, which are p53-dependent in certain cancer cell lines (Tam2008The). PDZD2's interactions highlight its role in modulating cellular signaling and maintaining protein stability.


## References


[1. (Tam2008The) Chun Wai Tam, Vincent Wing Sun Liu, Wai Ying Leung, Kwok-Ming Yao, and Stephen Yuen Wing Shiu. The autocrine human secreted pdz domain-containing protein 2 (spdzd2) induces senescence or quiescence of prostate, breast and liver cancer cells via transcriptional activation of p53. Cancer Letters, 271(1):64–80, November 2008. URL: http://dx.doi.org/10.1016/j.canlet.2008.05.047, doi:10.1016/j.canlet.2008.05.047. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2008.05.047)

[2. (Yeung2003Proteolytic) Man‐Lung Yeung, Tammy S M Tam, Anthony C C Tsang, and Kwok‐Ming Yao. Proteolytic cleavage of pdzd2 generates a secreted peptide containing two pdz domains. EMBO reports, 4(4):412–418, March 2003. URL: http://dx.doi.org/10.1038/sj.embor.embor804, doi:10.1038/sj.embor.embor804. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.embor.embor804)

[3. (Fai2020Secreted) Danny Hon Fai So, Joe Cho Yan Chan, Michelle Grace Tsui, Phyllis Siu Wai Tsang, and Kwok-Ming Yao. Secreted pdzd2 exerts an insulinotropic effect on ins-1e cells by a pka-dependent mechanism. Molecular and Cellular Endocrinology, 518:111026, December 2020. URL: http://dx.doi.org/10.1016/j.mce.2020.111026, doi:10.1016/j.mce.2020.111026. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2020.111026)

[4. (Shao2009A) Dongmin Shao, Mark D. Baker, Bjarke Abrahamsen, Francois Rugiero, Misbah Malik-Hall, W.-Y. Louisa Poon, Kathryn S.E. Cheah, Kwok-Ming Yao, John N. Wood, and Kenji Okuse. A multi pdz-domain protein pdzd2 contributes to functional expression of sensory neuron-specific sodium channel nav1.8. Molecular and Cellular Neuroscience, 42(3):219–225, October 2009. URL: http://dx.doi.org/10.1016/j.mcn.2009.07.003, doi:10.1016/j.mcn.2009.07.003. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mcn.2009.07.003)

[5. (Leung2009PDZDomain) Kwan Keung Leung, Po Man Suen, Tse Kin Lau, Wing Hung Ko, Kwok Ming Yao, and Po Sing Leung. Pdz-domain containing-2 (pdzd2) drives the maturity of human fetal pancreatic progenitor-derived islet-like cell clusters with functional responsiveness against membrane depolarization. Stem Cells and Development, 18(7):979–990, September 2009. URL: http://dx.doi.org/10.1089/scd.2008.0325, doi:10.1089/scd.2008.0325. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/scd.2008.0325)

[6. (Suen2008PDZdomain) P.M. Suen, C. Zou, Y.A. Zhang, T.K. Lau, J. Chan, K.M. Yao, and P.S. Leung. Pdz-domain containing-2 (pdzd2) is a novel factor that affects the growth and differentiation of human fetal pancreatic progenitor cells. The International Journal of Biochemistry &amp; Cell Biology, 40(4):789–803, 2008. URL: http://dx.doi.org/10.1016/j.biocel.2007.10.020, doi:10.1016/j.biocel.2007.10.020. This article has 36 citations.](https://doi.org/10.1016/j.biocel.2007.10.020)

[7. (Tsang2010Increased) S.W. Tsang, D. Shao, K.S.E. Cheah, K. Okuse, P.S. Leung, and K.-M. Yao. Increased basal insulin secretion in pdzd2-deficient mice. Molecular and Cellular Endocrinology, 315(1–2):263–270, February 2010. URL: http://dx.doi.org/10.1016/j.mce.2009.11.007, doi:10.1016/j.mce.2009.11.007. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2009.11.007)